“…62,99 Second, EoE appears to progress to fibrostenosis in many, although not all, patients with EoE, as evidenced by increasing stricture rates with longer symptom duration before diagnosis in adults, longer durations without therapeutic response after diagnosis, and modification of the esophageal transcriptome from inflammatory to epithelial differentiation pathways. 60,86,[100][101][102][103][104][105] Third, because treating the inflammatory component of the disease alone may not adequately alleviate symptoms, it is important to recognize fibrostenosis and consider performing esophageal dilation in symptomatic patients. 106,107 Finally, an ultimate goal should be to diagnose and treat EoE early enough, such that patients neither develop nor progress to fibrostenosis.…”